Med-X

Med-X

Early Stage

Making a Difference, Naturally.

Overview

Raised this Round: Raised: $7,000,471

Total Commitments ($USD)

Platform

StartEngine

Start Date

06/26/2018

Close Date

Not Provided

Min. Goal
$420
Max. Goal
$15,000,000
Min. Investment

$420

Security Type

Equity - Common

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$0.60

Year Founded

2014

Industry

Consumer Products, Goods & Services

Tech Sector

Cleantech

Location

Canoga Park, California

Med-X is raising funds on StartEngine through Reg A+ crowdfunding. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Dr. David Toomey and Matthew Mills founded Med-X in 2014. The current crowdfunding campaign has a maximum target of $15,000,000. The campaign proceeds will be used to continue positioning Nature-Cide and Thermal-Aid as all-natural alternatives to pest management, market and promote the products, and develop and market the medicinal compounds.

Balance Sheet

Cash and Cash Equivalents

$150,255

Accounts and Notes Receivable

$755

Property, Plant and Equipment (PP&E)

$187,313

Total Assets

$356,901

Accounts Payable & Accrued Liabilities

$315,952

Total Liabilities

$319,127

Total Stockholders' Equity

$37,774

Total Liabilities and Equity

$356,901

Statement of Comprehensive Income Information

Total Revenues

$27,269

Costs & Expenses Applicable to Rev

$7,752

Net Income

$-736,251

Earnings Per Share - Basic

$-0.01

Earnings Per Share - Diluted

$-0.01

Auditor: MJF & Associates APC
Financials as of: 06/26/2018
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 09/29/2024 Dealmaker Securities $50,894,025 $191,055 Equity - Common Active RegCF
Med-X 11/08/2023 Dalmore Group $102,217,405 $3,936,422 Equity - Common Funded RegA+
Med-X 05/22/2023 PicMii $43,211,544 $0 Equity - Common Not Funded RegCF
Med-X 09/09/2021 truCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/26/2019 StartEngine - $7,000,471 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Med-X on StartEngine 2018
Platform: StartEngine
Security Type: Equity - Common
Price per Share: $0.60

Follow company

Follow Med-X on StartEngine 2018

Buy Med-X's Deal Report

Warning: according to the close date for this deal, Med-X may no longer be accepting investments.

Med-X Deal Report

Get KingsCrowd’s comprehensive report on Med-X including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Med-X is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Med-X deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge